These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33346166)

  • 1. An insight on drug resistance in Plasmodium vivax, a still neglected human malaria parasite.
    L'Episcopia M; Perrotti E; Severini F; Picot S; Severini C
    Ann Ist Super Sanita; 2020; 56(4):409-418. PubMed ID: 33346166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, drug resistance, and pathophysiology of
    Dayananda KK; Achur RN; Gowda DC
    J Vector Borne Dis; 2018; 55(1):1-8. PubMed ID: 29916441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date.
    Ebstie YA; Abay SM; Tadesse WT; Ejigu DA
    Drug Des Devel Ther; 2016; 10():2387-99. PubMed ID: 27528800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and Treatment of Plasmodium vivax Malaria.
    Baird JK; Valecha N; Duparc S; White NJ; Price RN
    Am J Trop Med Hyg; 2016 Dec; 95(6 Suppl):35-51. PubMed ID: 27708191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal.
    Ranjitkar S; Schousboe ML; Thomsen TT; Adhikari M; Kapel CM; Bygbjerg IC; Alifrangis M
    Malar J; 2011 Apr; 10():75. PubMed ID: 21457533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoresistance of Plasmodium falciparum and Plasmodium vivax parasites in Brazil: consequences on disease morbidity and control.
    Gama BE; Lacerda MV; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
    Mem Inst Oswaldo Cruz; 2011 Aug; 106 Suppl 1():159-66. PubMed ID: 21881770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research progress on Plasmodium vivax chloroquine resistance].
    Li JY; Li Q; Fang Q
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2014 Jun; 26(3):326-31. PubMed ID: 25345166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasmodium resistance to antimalarials].
    Cailhol J; Consigny PH
    Rev Prat; 2014 Dec; 64(10):1433-4. PubMed ID: 25665330
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular and biological aspects of antimalarial resistance in Plasmodium falciparum and Plasmodium vivax.
    Bustamante C; Batista CN; Zalis M
    Curr Drug Targets; 2009 Mar; 10(3):279-90. PubMed ID: 19275564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-resistant malaria in children and in travelers.
    Longworth DL
    Pediatr Clin North Am; 1995 Jun; 42(3):649-64. PubMed ID: 7761145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptation of a chloroquine-resistant strain of Plasmodium vivax from Indonesia to New World monkeys.
    Collins WE; Sullivan JS; Fryauff DJ; Kendall J; Jennings V; Galland GG; Morris CL
    Am J Trop Med Hyg; 2000 Apr; 62(4):491-5. PubMed ID: 11220765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia.
    Fryauff DJ; Sumawinata I; Purnomo ; Richie TL; Tjitra E; Bangs MJ; Kadir A; Ingkokusumo G
    Am J Trop Med Hyg; 1999 Apr; 60(4):542-6. PubMed ID: 10348226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance.
    Price RN; Douglas NM; Anstey NM
    Curr Opin Infect Dis; 2009 Oct; 22(5):430-5. PubMed ID: 19571748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of high levels of mutations involved in anti-malarial drug resistance in Plasmodium falciparum and Plasmodium vivax at a rural hospital in southern Ethiopia.
    Mula P; Fernández-Martínez A; de Lucio A; Ramos JM; Reyes F; González V; Benito A; Berzosa P
    Malar J; 2011 Aug; 10():214. PubMed ID: 21810256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early transmission of sensitive strain slows down emergence of drug resistance in Plasmodium vivax.
    Ayala MJC; Villela DAM
    PLoS Comput Biol; 2020 Jun; 16(6):e1007945. PubMed ID: 32555701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic responses to different antimalarial drugs in vivax malaria.
    Pukrittayakamee S; Chantra A; Simpson JA; Vanijanonta S; Clemens R; Looareesuwan S; White NJ
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1680-5. PubMed ID: 10817728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis.
    Price RN; von Seidlein L; Valecha N; Nosten F; Baird JK; White NJ
    Lancet Infect Dis; 2014 Oct; 14(10):982-91. PubMed ID: 25213732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine-resistant Plasmodium vivax malaria in Serbo town, Jimma zone, south-west Ethiopia.
    Ketema T; Bacha K; Birhanu T; Petros B
    Malar J; 2009 Jul; 8():177. PubMed ID: 19642976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-resistant Plasmodium vivax malaria.
    Bradley JP
    N Z Med J; 1994 Jun; 107(979):228-9. PubMed ID: 8208487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.